FLETCHER R JOHN 4

4 · ClearPoint Neuro, Inc. · Filed May 21, 2026

AI-generated summary of this filing

Updated May 21, 2026

ClearPoint Neuro Director Fletcher R. John Receives 12,417 Shares

What Happened

Fletcher R. John, a director of ClearPoint Neuro, had 12,417 restricted stock units (RSUs) settle into 12,417 shares on May 19, 2026. The Form 4 records an "exercise/conversion of derivative (M)" acquiring 12,417 shares and a simultaneous disposition of 12,417 shares. No per‑share price or total dollar value is reported in the filing.

Key Details

Transaction date: May 19, 2026; Form 4 filed May 21, 2026 (appears timely).
Grant date / vesting terms: RSUs were granted May 22, 2025 and vested on the earlier of the first anniversary or the day before the 2026 annual meeting (per footnote).
Shares acquired: 12,417 (via RSU settlement). Simultaneous disposition: 12,417 (reason not specified in filing).
Price / value: Not disclosed (listed as N/A).
Shares owned after transaction: Not specified on the filing.
Footnote: Confirms each RSU converts to one share and this transaction represents scheduled RSU settlement.

Context

This was an RSU settlement (an award converting to shares), not an open‑market buy or sell. The filing also shows a matching disposition of the same shares; the Form 4 does not state the reason (e.g., tax withholding or transfer). RSU settlements are routine compensation events and do not, by themselves, indicate insider sentiment. For further detail, consult the full Form 4 and the company’s disclosures.

Form 4

Period: 2026-05-19

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-05-19+12,417→ 130,349 total
Exercise/Conversion
Restricted Stock Units
[F1]
2026-05-19−12,417→ 0 total
→ Common Stock (12,417 underlying)

Footnotes (1)

[F1]Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Signature

/s/ Danilo D'Alessandro, by Power of Attorney for R. John Fletcher|2026-05-21

1 file